NCT00047788View on ClinicalTrials.gov

Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

May 31, 2004

Conditions
Multiple Myeloma
Interventions
DRUG

ZD6474

DRUG

VEGF-receptor tyrosine kinase (KDR)

Trial Locations (7)

Unknown

Research Site, New York

Research Site, Edmonton

Research Site, Halifax

Research Site, Hamilton

Research Site, London

Research Site, Toronto

Research Site, Montreal

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00047788 - Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer | Biotech Hunter | Biotech Hunter